Remove topics estoppel
article thumbnail

[Webinar] Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2022 Decisions - February 2nd, 1:00 pm - 2:00 pm EST

JD Supra Law

Topics of the featured intellectual property cases include: exclusion of expert testimony, the ITC’s ability to enforce consent orders, estoppel by IPR final written decisions, standing to challenge PTAB decisions on appeal, obviousness in light of overlapping ranges in the prior art, and settlements of IPRs before.

article thumbnail

[Video] Webinar | Post-Grant for Practitioners: Post-Grant Appeals

JD Supra Law

However, ongoing disputes – specifically those concerning estoppel, obviousness, and the reviewability of PTAB institution decisions – continue to be major issues in post-grant jurisprudence. The Federal Circuit has issued several rulings on these topics that will have major implications for practitioners. By: Fish & Richardson

Law 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

[Webinar] 2022 PTAB Year in Review: Analysis and Trends - February 28th, 1:00 pm - 2:00 pm EST

JD Supra Law

Speakers will offer updates, case summaries, and analysis of the significant 2022 PTAB guidance, actions, and rulings.

Art 52
article thumbnail

Account Suspension Lawsuit Against Twitter Survives Motion to Dismiss–Berenson v. Twitter

Technology & Marketing Law Blog

Judge Alsup dismisses most of Berenson’s claims, but the contract breach and promissory estoppel claims survive Twitter’s motion to dismiss. Still, I prefer it when judges rely on Section 230(c)(1) to take the “good faith” topic off the table entirely. ” Contract Breach/Promissory Estoppel.

article thumbnail

PTAB Default Should Be In-Person Trial Hearings

LexBlog IP

The changes include rather mundane clarifications on such topics as public access and demonstrative submission for ex parte hearings. But as a practitioner it is not my patent or estoppel risk hanging in the balance. But, in practice this option is more appropriately considered the new default. I prefer them by a wide margin.

article thumbnail

Seeing Clearly: Article III Standing of IPR Judicial Review

Patently-O

Article III standing remains a hot topic at all levels of federal litigation and across many different areas of law. With surgery as the only viable course of treatment, Cloudbreak Therapeutics created a topical application of multikinase inhibitors to provide a non-surgical treatment to prevent recurring tumors, which is recognized in U.S.

Art 49
article thumbnail

Supreme Court on Patent Law for October 2022

Patently-O

Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) Post IPR Estoppel in Apple Inc. I have subjectively ordered the cases with the most important or most likely cases toward the top. Caltech , No.